Dec 14 (Reuters) - Valbiotis SA ALVAL.PA :
* VALBIOTIS ANNOUNCES SIGNATURE OF A RESEARCH PARTNERSHIP IN
INTESTINAL MICROBIOTA WITH MEDIS UNIT FROM CLERMONT AUVERGNE
UNIVERSITY
* THIS WORK WILL MAKE IT POSSIBLE TO DEVELOP THE WORLD'S
MOST
COMPLETE MODEL OF THE HUMAN UPPER DIGESTIVE TRACT BY 2024,
INTEGRATING IN PARTICULAR THE MICROBIOTA OF THE SMALL INTESTINE.
* EXPECTED RESULTS WILL SUPPORT NON-DRUG STRATEGIES AGAINST
METABOLIC AND CARDIOVASCULAR DISEASES DEVELOPED BY VALBIOTIS
* MIMETIV PROJECT WILL PROVIDE PROPRIETARY DATA ON
METABOLITES,
BIOAVAILABILITY, MODE OF ACTION AT INTESTINAL LEVEL AND EFFECTS
ON THE HUMAN MICROBIOTA OF THESE TWO ACTIVE SUBSTANCES
Source text for Eikon: ID:nBwbjXt9qa
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))